What is Vistagen Therapeutics, Inc. Common Stock's Market Cap?

Vistagen Therapeutics, Inc. Common Stock's Market Cap is $10.8M, based on as-reported figures from SEC (XBRL) filings.

What is Vistagen Therapeutics, Inc. Common Stock's Price / Sales?

Vistagen Therapeutics, Inc. Common Stock's Price / Sales is 4.3×, based on as-reported figures from SEC (XBRL) filings.

What is Vistagen Therapeutics, Inc. Common Stock's Revenue (TTM)?

Vistagen Therapeutics, Inc. Common Stock's Revenue (TTM) is $2.5M, based on as-reported figures from SEC (XBRL) filings.

What is Vistagen Therapeutics, Inc. Common Stock's Net Income (TTM)?

Vistagen Therapeutics, Inc. Common Stock's Net Income (TTM) is -$67.6M, based on as-reported figures from SEC (XBRL) filings.

What is Vistagen Therapeutics, Inc. Common Stock's EBITDA?

Vistagen Therapeutics, Inc. Common Stock's EBITDA is -$69.5M, based on as-reported figures from SEC (XBRL) filings.

What is Vistagen Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Vistagen Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.52, based on as-reported figures from SEC (XBRL) filings.

What is Vistagen Therapeutics, Inc. Common Stock's EBITDA Margin?

Vistagen Therapeutics, Inc. Common Stock's EBITDA Margin is -2777.2%, based on as-reported figures from SEC (XBRL) filings.

Vistagen Therapeutics, Inc. Common Stock (VTGN) Financial Statements

Vistagen Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S67BH3

XNAS · usd

0.24▼ 0.00 (-0.12%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close0.24

Day's Range0.24 – 0.25

52-Week Range0.20 – 5.14

Volume309.3K

Avg Volume4.9M

Share Statistics

Shares Outstanding

Employees59

ExchangeXNAS

Listed2009-07-01

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Vistagen Therapeutics, Inc. Common Stock (VTGN)

What is Vistagen Therapeutics, Inc. Common Stock's Market Cap?: Vistagen Therapeutics, Inc. Common Stock's Market Cap is $10.8M, based on as-reported figures from SEC (XBRL) filings.
What is Vistagen Therapeutics, Inc. Common Stock's Price / Sales?: Vistagen Therapeutics, Inc. Common Stock's Price / Sales is 4.3×, based on as-reported figures from SEC (XBRL) filings.
What is Vistagen Therapeutics, Inc. Common Stock's Revenue (TTM)?: Vistagen Therapeutics, Inc. Common Stock's Revenue (TTM) is $2.5M, based on as-reported figures from SEC (XBRL) filings.
What is Vistagen Therapeutics, Inc. Common Stock's Net Income (TTM)?: Vistagen Therapeutics, Inc. Common Stock's Net Income (TTM) is -$67.6M, based on as-reported figures from SEC (XBRL) filings.
What is Vistagen Therapeutics, Inc. Common Stock's EBITDA?: Vistagen Therapeutics, Inc. Common Stock's EBITDA is -$69.5M, based on as-reported figures from SEC (XBRL) filings.
What is Vistagen Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Vistagen Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.52, based on as-reported figures from SEC (XBRL) filings.
What is Vistagen Therapeutics, Inc. Common Stock's EBITDA Margin?: Vistagen Therapeutics, Inc. Common Stock's EBITDA Margin is -2777.2%, based on as-reported figures from SEC (XBRL) filings.